Vanguard Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $409M | Buy |
11,514,326
+3,756,664
| +48% | +$106M | 0.01% | 1169 |
|
|
2025
Q3 | $111M | Buy |
7,757,662
+1,234,711
| +19% | +$14.6M | ﹤0.01% | 1812 |
|
|
2025
Q2 | $46.8M | Buy |
6,522,951
+464,613
| +8% | +$2.58M | ﹤0.01% | 2155 |
|
|
2025
Q1 | $36.3M | Sell |
6,058,338
-75,042
| -1% | -$588K | ﹤0.01% | 2238 |
|
|
2024
Q4 | $47.8M | Buy |
6,133,380
+418,975
| +7% | +$4.18M | ﹤0.01% | 2175 |
|
|
2024
Q3 | $61.7M | Buy |
5,714,405
+454,526
| +9% | +$4.43M | ﹤0.01% | 2083 |
|
|
2024
Q2 | $44.3M | Sell |
5,259,879
-505,826
| -9% | -$3.84M | ﹤0.01% | 2194 |
|
|
2024
Q1 | $38.7M | Buy |
5,765,705
+1,231,050
| +27% | +$7.61M | ﹤0.01% | 2274 |
|
|
2023
Q4 | $26.7M | Buy |
4,534,655
+161,344
| +4% | +$1.24M | ﹤0.01% | 2466 |
|
|
2023
Q3 | $42.6M | Sell |
4,373,311
-63,310
| -1% | -$751K | ﹤0.01% | 2203 |
|
|
2023
Q2 | $52.5M | Buy |
4,436,621
+900,362
| +25% | +$10.3M | ﹤0.01% | 2159 |
|
|
2023
Q1 | $38.2M | Buy |
3,536,259
+70,467
| +2% | +$901K | ﹤0.01% | 2297 |
|
|
2022
Q4 | $40.1M | Buy |
3,465,792
+282,022
| +9% | +$3.49M | ﹤0.01% | 2293 |
|
|
2022
Q3 | $47.5M | Buy |
3,183,770
+597,966
| +23% | +$8.2M | ﹤0.01% | 2208 |
|
|
2022
Q2 | $23.3M | Buy |
2,585,804
+942,835
| +57% | +$6.44M | ﹤0.01% | 2567 |
|
|
2022
Q1 | $12.3M | Sell |
1,642,969
-9,764
| -0.6% | -$68K | ﹤0.01% | 3041 |
|
|
2021
Q4 | $14.2M | Buy |
1,652,733
+55,617
| +3% | +$484K | ﹤0.01% | 3032 |
|
|
2021
Q3 | $13.4M | Sell |
1,597,116
-9,673
| -0.6% | -$74.1K | ﹤0.01% | 3079 |
|
|
2021
Q2 | $13M | Sell |
1,606,789
-527,454
| -25% | -$4.46M | ﹤0.01% | 3073 |
|
|
2021
Q1 | $18.7M | Buy |
2,134,243
+1,275,692
| +149% | +$12.3M | ﹤0.01% | 2818 |
|
|
2020
Q4 | $9.64M | Buy |
858,551
+717,777
| +510% | +$7.89M | ﹤0.01% | 3012 |
|
|
2020
Q3 | $1.32M | Buy |
140,774
+15,129
| +12% | +$158K | ﹤0.01% | 3596 |
|
|
2020
Q2 | $231K | Sell |
125,645
-5,438
| -4% | -$10.1K | ﹤0.01% | 3910 |
|
|
2020
Q1 | $217K | Sell |
131,083
-165
| -0.1% | -$459 | ﹤0.01% | 3851 |
|
|
2019
Q4 | $378K | Sell |
131,248
-281
| -0.2% | -$1.15K | ﹤0.01% | 3848 |
|
|
2019
Q3 | $758K | Buy |
131,529
+29,576
| +29% | +$240K | ﹤0.01% | 3717 |
|
|
2019
Q2 | $1.07M | Sell |
101,953
-8,502
| -8% | -$113K | ﹤0.01% | 3657 |
|
|
2019
Q1 | $1.94M | Buy |
110,455
+64,348
| +140% | +$1.1M | ﹤0.01% | 3462 |
|
|
2018
Q4 | $812K | Sell |
46,107
-91,988
| -67% | -$2.72M | ﹤0.01% | 3623 |
|
|
2018
Q3 | $5.69M | Buy |
138,095
+5,627
| +4% | +$317K | ﹤0.01% | 3184 |
|
|
2018
Q2 | $7.6M | Buy |
132,468
+38,943
| +42% | +$1.87M | ﹤0.01% | 3038 |
|
|
2018
Q1 | $4.16M | Buy |
+93,525
| New | +$4.16M | ﹤0.01% | 3221 |
|
Other funds holding COGT
DM
FFM
RI
KCM
TCM
